ZOLL Medical News
2 articles
growth-positive
Israeli sleep diagnostics co Itamar Medical sold for $538m
Itamar Medical, a company that produces devices for diagnosing sleep disorders, is being acquired by ZOLL Medical for $538 million. The acquisition price represents a 50% premium over Itamar Medicals share price. Itamar Medicals share price has increased by nearly 34% in response to the news. The deal is subject to approval and is expected to be completed within three to four months. Itamar Medicals activity will continue at its current offices and labs. The company has benefited from the COVID-19 pandemic, as it has gained market share in home sleep diagnostic devices. The combination of Itamar Medicals technology and ZOLL Medicals market presence will support the diagnosis and treatment of sleep apnea patients.
Acquisition
growth-positive
ZOLL acquires Israeli co Kyma Medical for $35m
US medical device company ZOLL Medical Corp. has acquired Israeli company Kyma Medical Technologies Ltd. for $35 million plus milestone payments. Kyma has developed a remote patient monitoring system for fluid management in patients suffering from heart failure. The acquisition will allow ZOLL to broaden its product offerings and improve outcomes for heart failure patients. Kymas facilities and workforce will be maintained in Israel and California as part of ZOLLs LifeVest division.
Acquisition